arGEN-X News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.06.24	Argenx To Unveil 'Vision 2030' (RTTNews)
09.05.24	Argenx Posts Wider Than Expected Q1 Loss; Operating Income Climbs (RTTNews)
26.03.24	Argenx's Vyvgart Approved In Japan For Adults With Primary Immune Thrombocytopenia (RTTNews)
20.02.24	Argenx's VYVGART Hytrulo Granted Priority Review By FDA For CIDP (RTTNews)
18.01.24	Argenx: Japan's Ministry Of Health Approves VYVDURA Injection For Subcutaneous Use (RTTNews)
20.12.23	Argenx : Phase 3 Study Of Efgartigimod SC In Pemphigus Fails To Meet Primary & Secondary Endpoints (RTTNews)
28.11.23	Argenx's VYVGART Hytrulo Trial In Primary Immune Thrombocytopenia Fails To Meet Key Goals (RTTNews)
16.11.23	Argenx Announces EC Approval For Subcutaneous Vyvgart For Generalized Myasthenia Gravis (RTTNews)
21.09.23	Argenx's Vyvgart Authorized For Sale In Canada For Generalized Myasthenia Gravis (RTTNews)
15.09.23	Argenx: CHMP Recommends EC Approval For Subcutaneous Efgartigimod For Generalized Myasthenia Gravis (RTTNews)
21.07.23	These 9 Stocks Touched New 52-Week High - Were They In Your Portfolio? (RTTNews)
17.07.23	Zai Lab, Argenx Report Positive Data From Trial Of VYVGART Hytrulo In CIDP (RTTNews)
30.11.22	Argenx To Acquire FDA Priority Review Voucher - Quick Facts (RTTNews)
22.11.22	Argenx : FDA Accepts BLA For SC Efgartigimod In Generalized Myasthenia Gravis With Priority Review (RTTNews)
28.10.22	ALNY Reiterates Guidance, TVTX Loss Widens, DXCM Paints Rosy Outlook (RTTNews)
21.09.22	Argenx Submits BLA To FDA For Subcutaneous Efgartigimod For Generalized Myasthenia Gravis Treatment (RTTNews)
29.07.22	Alnylam Q2 Loss Widens, SGEN Boosts Revenue Outlook, NVCR To Report LUNAR Study Data In Q1 (RTTNews)
24.06.22	Argenx Stock Up On Positive CHMP Opinion For Efgartigimod For GMG Patients In Europe (RTTNews)
22.03.22	Halozyme: ENHANZE Drug Delivery Technology Part Of Argenx's Positive Trial Of SC Efgartigimod In GMG (RTTNews)
22.03.22	Argenx: SC Efgartigimod Meets Primary Endpoint In Phase 3 ADAPT-SC Trial In GMG - Quick Facts (RTTNews)
20.12.21	Argenx Trading 8% Up In Morning Trade (RTTNews)
20.12.21	FDA Approves Argenx's Vyvgart To Treat Myasthenia Gravis (RTTNews)
29.11.21	Biotech Stocks Facing FDA Decision In December 2021 (RTTNews)
07.06.21	Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag (RTTNews)
15.12.20	Argenx Stock Breaches $300 Mark (RTTNews)
23.11.20	Argenx To Buy FDA Priority Review Voucher From Bayer Healthcare For $98 Mln (RTTNews)
04.11.20	Pre-market Movers In Healthcare Sector: DRAD, SUPN, ARGX, AZN, APVO… (RTTNews)
27.05.20	ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch (RTTNews)
26.05.20	Stock Alert: Argenx Up 30% As Muscular Disorder Drug Meets Phase 3 Trial Goal (RTTNews)
26.05.20	Stock Alert: Argenx Shares Up 30% On Topline Data From Phase 3 ADAPT Trial Of Efgartigimod (RTTNews)
02.07.19	Argenx's Impressive Journey From $25 To $140 (RTTNews)
12.10.18	ATXI Abuzz, CRMD On Watch, AMRN Back In Focus (RTTNews)
04.09.18	Is There Still Room To Run For These Biotech Stocks? (RTTNews)
20.06.18	Argenx Reports Interim Data From Phase 2 Proof-of-concept Trial Of Efgartigimod (RTTNews)
21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
09.04.18	Argenx Names Keith Woods COO - Quick Facts (RTTNews)
30.01.18	AKCA ON The Move, MNLO Makes A Mark, OBSV Looks Ahead With Hope, ARGX Soars (RTTNews)
15.12.17	GHDX Soars On Takeover Rumors, MRNS, TOCA Join NBI, There's No Stopping ARGX (RTTNews)
12.12.17	ARGX Soars, SNSS Catches Eyes, BPMC, BLUE Turn Heads, FDA Nod For SNNA (RTTNews)
04.12.17	ASH: Here's Why You Need To Keep An Eye On ARGX, MGNX, KURA, AGIO (RTTNews)
01.12.17	BEAT Upbeat, SYRS Gearing Up For ASH, Catalyst-Rich Year Ahead For ARGX (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu arGEN-X SE (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten